MX2020010424A - Comprimido o composicion que contiene n-acil etanolamina y cannabinoides. - Google Patents

Comprimido o composicion que contiene n-acil etanolamina y cannabinoides.

Info

Publication number
MX2020010424A
MX2020010424A MX2020010424A MX2020010424A MX2020010424A MX 2020010424 A MX2020010424 A MX 2020010424A MX 2020010424 A MX2020010424 A MX 2020010424A MX 2020010424 A MX2020010424 A MX 2020010424A MX 2020010424 A MX2020010424 A MX 2020010424A
Authority
MX
Mexico
Prior art keywords
composition
cannabinoid
tablet
acyl ethanolamine
ethanolamine
Prior art date
Application number
MX2020010424A
Other languages
English (en)
Inventor
John Althaus
Stephen Goldner
Debra Kimless
Original Assignee
Pure Green Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pure Green Pharmaceuticals Inc filed Critical Pure Green Pharmaceuticals Inc
Publication of MX2020010424A publication Critical patent/MX2020010424A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición incluye N-acil-etanolamina, al menos un cannabinoide y al menos un terpeno. La composición puede encontrarse en la forma de un comprimido.
MX2020010424A 2018-04-03 2019-04-03 Comprimido o composicion que contiene n-acil etanolamina y cannabinoides. MX2020010424A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862651775P 2018-04-03 2018-04-03
PCT/US2019/025476 WO2019195355A1 (en) 2018-04-03 2019-04-03 Tablet or composition having n-acyl ethanolamine and cannabinoid

Publications (1)

Publication Number Publication Date
MX2020010424A true MX2020010424A (es) 2021-01-15

Family

ID=68101116

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020010424A MX2020010424A (es) 2018-04-03 2019-04-03 Comprimido o composicion que contiene n-acil etanolamina y cannabinoides.

Country Status (5)

Country Link
US (1) US11951086B2 (es)
EP (1) EP3773512A4 (es)
CA (1) CA3096062A1 (es)
MX (1) MX2020010424A (es)
WO (1) WO2019195355A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4284351A1 (en) * 2021-01-28 2023-12-06 Specchiasol S.r.l. Composition for the treatment of painful and/or inflammatory states

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160094950A (ko) 2013-10-31 2016-08-10 풀 스펙트럼 래버러토리즈, 리미티드 테르펜 및 칸나비노이드 제제
US9044390B1 (en) * 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US20160039591A1 (en) * 2014-07-22 2016-02-11 Craig E. Kinzer Packaging systems, devices, methods, and composition including cannabinoid unit dose forms
JP6938465B2 (ja) * 2015-04-29 2021-09-22 エスシーアイ スパーク リミティド カンナビノイドとｎ−アシルエタノールアミンの組み合わせ
US11166912B2 (en) * 2016-03-03 2021-11-09 Ctt Pharma Inc. Orally administrable composition
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
US20210052478A1 (en) * 2018-01-05 2021-02-25 Altus Labs, Llc Personal care compositions

Also Published As

Publication number Publication date
WO2019195355A9 (en) 2019-12-05
WO2019195355A1 (en) 2019-10-10
CA3096062A1 (en) 2019-10-10
EP3773512A1 (en) 2021-02-17
EP3773512A4 (en) 2021-12-29
US20210015774A1 (en) 2021-01-21
US11951086B2 (en) 2024-04-09

Similar Documents

Publication Publication Date Title
PH12020500398A1 (en) Antibody-pyrrolobenzodiazepine derivative conjugate
MY194032A (en) Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof
SG11201811571WA (en) Discharge device and method for manufacturing same
MX2020004071A (es) Derivados de aztreonam y usos de los mismos.
PH12020550556A1 (en) Novel combinations of defoliants
WO2020127145A3 (de) Materialien für elektronische vorrichtungen
MX2021013417A (es) Polipeptidos de union a la proteina del miembro a de la familia 12 del dominio de lectina tipo c (clec12a) y sus usos.
MX2019010643A (es) Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2).
PH12021550289A1 (en) Ox40-binding polypeptides and uses thereof
WO2020127259A3 (en) Materials for electronic devices
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
MX2023006458A (es) Oligosacaridos inmunomoduladores.
SG10201901275PA (en) Storage device and server including the storage device
MX2020001557A (es) Combinaciones herbicidas sinergicas.
PH12020552158A1 (en) Combination of poziotinib with cytotoxic agent and/or other molecularly targeted agent and use thereof
MX2020010424A (es) Comprimido o composicion que contiene n-acil etanolamina y cannabinoides.
SG10201806014TA (en) Feedback canceller and hearing aid
AU201815763S (en) Quick connection coupler
WO2016144125A3 (ko) 용규 추출물의 신규 용도
EP3993874A4 (en) Cd38-binding agents and uses thereof
EP3993818A4 (en) CD38 BINDING AGENT AND RELATED USES
MX2021007200A (es) Complejo de zinc-arginina-cloruro.
MX2020003513A (es) Composiciones de ingredientes activos que comprenden n-alquenoil-n-alquilglucamidas y el uso de los mismos.
MX2018008376A (es) Composiciones de fragancia de liberacion prolongada.
CA192193S (en) Perfume bottle